Prevalence and harm of nonalcoholic fatty liver disease 
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1007-3418.2019.01.004
   		
        
        	
        		- VernacularTitle: 非酒精性脂肪性肝病的流行现状与危害 
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Youlin SHAO
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jiangao FAN
			        		
			        		
			        		
			        			2
			        			
			        		
			        		
			        		
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Hepatology, Changzhou Third People's Hospital, Changzhou 213001, Jiangsu Province, China
			        		
			        			2. Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Fatty liver, nonalcoholic;
			        		
			        		
			        		
				        		Epidemiology;
			        		
			        		
			        		
				        		Comorbidity
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Hepatology
	            		
	            		 2019;27(1):10-13
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Worldwide increasing prevalence of obesity and lifestyle changes has put nonalcoholic fatty liver disease (NAFLD) as the most prevalent liver disease of the coming decade. NAFLD not only causes cirrhosis and hepatocellular carcinoma, but also acts as a component of metabolic syndrome together with obesity, type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and dyslipidemia. Consequently, its mutual cause-and-effect interactions have brought a huge clinical and financial burden to patients and society.